Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Journal: Chest
PMID:

Abstract

COPD is a heterogeneous syndrome. Many COPD subtypes have been proposed, but there is not yet consensus on how many COPD subtypes there are and how they should be defined. The COPD Genetic Epidemiology Study (COPDGene), which has generated 10-year longitudinal chest imaging, spirometry, and molecular data, is a rich resource for relating COPD phenotypes to underlying genetic and molecular mechanisms. In this article, we place COPDGene clustering studies in context with other highly cited COPD clustering studies, and summarize the main COPD subtype findings from COPDGene. First, most manifestations of COPD occur along a continuum, which explains why continuous aspects of COPD or disease axes may be more accurate and reproducible than subtypes identified through clustering methods. Second, continuous COPD-related measures can be used to create subgroups through the use of predictive models to define cut-points, and we review COPDGene research on blood eosinophil count thresholds as a specific example. Third, COPD phenotypes identified or prioritized through machine learning methods have led to novel biological discoveries, including novel emphysema genetic risk variants and systemic inflammatory subtypes of COPD. Fourth, trajectory-based COPD subtyping captures differences in the longitudinal evolution of COPD, addressing a major limitation of clustering analyses that are confounded by disease severity. Ongoing longitudinal characterization of subjects in COPDGene will provide useful insights about the relationship between lung imaging parameters, molecular markers, and COPD progression that will enable the identification of subtypes based on underlying disease processes and distinct patterns of disease progression, with the potential to improve the clinical relevance and reproducibility of COPD subtypes.

Authors

  • Peter J Castaldi
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: repjc@channing.harvard.edu.
  • Adel Boueiz
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Jeong Yun
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Raul San Jose Estepar
    Applied Chest Imaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • James C Ross
    2 Applied Chest Imaging Laboratory, Department of Radiology, and.
  • George Washko
    2 Brigham and Women's Hospital Boston, Massachusetts.
  • Michael H Cho
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Craig P Hersh
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Gregory L Kinney
    Department of Epidemiology, University of Colorado, Denver, Aurora, CO.
  • Kendra A Young
    Department of Epidemiology, University of Colorado, Denver, Aurora, CO.
  • Elizabeth A Regan
    National Jewish Health, Denver, CO.
  • David A Lynch
    National Jewish Health, Denver, CO, USA.
  • Gerald J Criner
    Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
  • Jennifer G Dy
  • Stephen I Rennard
    Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE.
  • Richard Casaburi
    Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
  • Barry J Make
    National Jewish Health, Denver, CO.
  • James Crapo
    National Jewish Health, Denver, CO.
  • Edwin K Silverman
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • John E Hokanson
    Department of Epidemiology, University of Colorado, Denver, Aurora, CO.